Perella Weinberg Partners has announced that Jason D. Forschler has joined the Firm as a Managing Director in its Advisory business.
Based in San Francisco, Forschler will focus on providing strategic and financial advice to clients in the healthcare sector.
Forschler has over a decade of healthcare investment banking experience. He was most recently an Executive Director in the Healthcare Investment Banking Group at J.P. Morgan, where he advised a broad range of healthcare clients. Prior to that, Mr. Forschler was an Associate on the Healthcare team at Piper Jaffray and he started his career at Deloitte & Touche.
Peter Weinberg, Partner and Head of Advisory at Perella Weinberg Partners, said, 'Last year was a transformative year for the Firm’s healthcare practice and building on that momentum is a key priority. Healthcare continues to be one of the most active sectors and we look forward to further enhancing our healthcare coverage through Jason’s addition.”
Forschler stated, 'Perella Weinberg Partners is a well-respected independent advisory firm with a strong track record of providing strategic advice to healthcare clients. I am excited to join this team of high-quality advisory professionals and look forward to leveraging my experience to the benefit of our clients'.
Perella Weinberg Partners has been actively advising healthcare clients, including:
• Medtronic in connection with the acquisition of Covidien for $42.9 billion;
• CareFusion on its sale to Becton, Dickinson and Company for $12.2 billion;
• Wright Medical Group in connection with its merger with Tornier N.V. for $3.3 billion;
• Lumara Health in connection with its sale to AMAG Pharmaceuticals for $1 billion;
• Wright Medical Group in connection with its $633 million senior notes offering; and
• PerkinElmer in connection with the acquisition of Perten Instruments AB for $266 million.
defense advisory, financial restructuring, private capital raising, and pension matters. The Asset
Management business includes a suite of hedge fund strategies, private investment funds (including